Our Mission
The SSADH Association is a voluntary, not-for-profit, 501(c) (3) organization dedicated to helping children and families affected by an ultra-rare neurometabolic disorder known as Succinic Semialdehyde Dehydrogenase Deficiency or SSADH.
The SSADH Association is committed to those affected with this neurotransmitter disease through education, advocacy and research.
News & Updates
Proceedings Published from Virtual Conference
The manuscripts from the 2020 Virtual SSADH Conference are being published on-line through the Journal of Child Neurology. We are…
Read More
$100,000 Awarded to WSU
The amount of $100,000 was awarded to Drs. Gibson and Roullet at Washington State University to extend the initial funding…
Read More
Celebrating Rare Disease Day
Celebrating Rare Disease Day 2021! On February 25th, Washington State University (WSU) took the time to recognize Rare Disease Day. The…
Read More
Inducible SSADH Mouse Model
In early 2020, Drs. Rotenberg and Lee from Boston Children’s Hospital were given a one year $100,000 grant to create…
Read MoreThe 2020 Virtual SSADH Conference was held July 9 and 10, 2020 was a huge success! We are happy to share that we had over 300 individuals register, representing 25 countries.
Below are the links to the recording for each session. The recordings will be available until early 2021.
2020 SSADH Conference - Session 1
2020 SSADH Conference - Session 2
2020 SSADH Conference - Session 3
2020 SSADH Conference - Session 4
Additionally, the proceedings from this conference are being published as individual manuscripts in the Journal of Child Neurology. As they become available they will be posted under the news section. To read the articles click here.
Many thanks to the Conference Organizers: Dr. Jean-Baptiste Roullet, Dr. K. Michael Gibson
Dr. Phillip Pearl, Dr. Melissa DiBacco, Alice McConnell, & Carolyn Hoffman
